Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Osaid Alser

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United StatesEdward Burn, Anthony G Sena, Albert Prats-Uribe, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and SpainElena Roel, Andrea Pistillo, Martina Recalde, et al.
BMJ Global Health|December 5, 2020
Infection and mortality of healthcare workers worldwide from COVID-19: a systematic reviewSoham Bandyopadhyay, Ronnie E Baticulon, Murtaza Kadhum, et al.
Research Square|March 10, 2021
Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDISDaniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network studyEdward Burn, Seng Chan You, Anthony Sena, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Use of dialysis, tracheostomy, and extracorporeal membrane oxygenation among 842,928 patients hospitalized with COVID-19 in the United StatesEdward Burn, Anthony G Sena, Albert Prats-Uribe, et al.
BMJ (Clinical Research Ed.)|May 12, 2021
Use of repurposed and adjuvant drugs in hospital patients with covid-19: multinational network cohort studyAlbert Prats-Uribe, Anthony G Sena, Lana Yin Hui Lai, et al.
Medrxiv : the Preprint Server for Health Sciences|December 3, 2020
Characteristics, outcomes, and mortality amongst 133,589 patients with prevalent autoimmune diseases diagnosed with, and 48,418 hospitalised for COVID-19: a multinational distributed network cohort analysisEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Rheumatology (Oxford, England)|December 28, 2020
Risk of depression, suicide and psychosis with hydroxychloroquine treatment for rheumatoid arthritis: a multinational network cohort studyJennifer C E Lane, James Weaver, Kristin Kostka, et al.
Rheumatology (Oxford, England)|March 16, 2021
COVID-19 in patients with autoimmune diseases: characteristics and outcomes in a multinational network of cohorts across three countriesEng Hooi Tan, Anthony G Sena, Albert Prats-Uribe, et al.
Medrxiv : the Preprint Server for Health Sciences|November 3, 2020
Baseline phenotype and 30-day outcomes of people tested for COVID-19: an international network cohort including >3.32 million people tested with real-time PCR and >219,000 tested positive for SARS-CoV-2 in South Korea, Spain and the United StatesAsieh Golozar, Lana Yh Lai, Anthony G Sena, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 17, 2021
Characteristics and Outcomes of Over 300,000 Patients with COVID-19 and History of Cancer in the United States and SpainElena Roel, Andrea Pistillo, Martina Recalde, et al.
BMJ Global Health|December 5, 2020
Infection and mortality of healthcare workers worldwide from COVID-19: a systematic reviewSoham Bandyopadhyay, Ronnie E Baticulon, Murtaza Kadhum, et al.
Research Square|March 10, 2021
Unraveling COVID-19: a large-scale characterization of 4.5 million COVID-19 cases using CHARYBDISDaniel Prieto-Alhambra, Kristin Kostka, Talita Duarte-Salles, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Deep phenotyping of 34,128 patients hospitalised with COVID-19 and a comparison with 81,596 influenza patients in America, Europe and Asia: an international network studyEdward Burn, Seng Chan You, Anthony Sena, et al.
Pageof 7